Machine learning predicts mouse lifespan-extending compounds (preprint)
A preprint on bioRxiv describes a computer model that tries to identify, from mouse lifespan data, which drugs could extend life. The study has not yet been peer reviewed.
Source: Machine Learning Predicts Mouse Lifespan-Extending Compounds (Preprint) (biorxiv.org). Summary written with AI from the source and reviewed by rules; read the original.
What the research shows
A preprint posted on bioRxiv describes a computational study in which a random forest model, a type of machine learning, was trained on mouse lifespan data from the DrugAge database. The model was then applied to drugs from the DrugBank database to estimate which compounds might extend life. The work shows how computational screening can help prioritize compounds for later testing in aging research.
Because this is a preprint, it has not yet gone through peer review, the stage where other experts assess methods and conclusions before journal publication. As a computational study, its predictions would need to be confirmed by experiments before any conclusion about real effects could be drawn. Predictive models also depend on the quality of their training data and may not hold up.
What it means
The finding suggests computer models may help choose candidates for testing, but it does not show that any drug actually extends life. It is still unknown which predictions would hold up in animal experiments and how accurate the predictions are.
How to read it with care
Read this result with caution: it is a preprint without peer review, and a computational prediction does not replace experiments. It is not a recommendation to use any medicine or supplement. Anyone considering a change in diet, supplements or treatment should talk to a doctor or another qualified health professional.